Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

Share Price Information for Totally (TLY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.10
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.80 (17.021%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.10
TLY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of Share Options

21 Jan 2015 07:00

RNS Number : 6919C
Totally PLC
21 January 2015
 

 

21 January 2015

 

Totally plc

("Totally" or "the Company")

 

Grant of Share Options

 

The Board of Totally (AIM: TLY), the provider of a range of services to the healthcare sector, announces the grant of 30,000,000 options to subscribe for new ordinary shares of 0.1 pence each in the Company (the "Options") to certain directors and senior management of the Company on 20 January 2015 (the "Grant Date"). 16,000,000 Options have been granted under the Company's existing Enterprise Management Incentive ("EMI") Scheme and 14,000,000 Options have been granted as unapproved share options.

 

The Options have an exercise price of 0.5 pence per share, a 66.7% premium to the closing mid-market price of 0.3 pence per ordinary share on 20 January 2015.

 

24,000,000 Options have been issued to existing directors of the Company representing 6.04% of the Company's current issued share capital. In addition, a further 6,000,000 Options have been issued to certain senior employees in the Company, representing 1.51% of the Company's current issued share capital.

 

The Options issued to directors are detailed below:

 

Name

Current number of Options held

Number of Options granted

Type of grant

Total number of Options now held

Per cent. of current issued share capital

Number of Ordinary Shares held

Number of Warrants held

Dr. Michael Sinclair

(Non-Executive Chairman)

 

0

5,000,000

Unapproved share options

5,000,000

1.26%

19,731,792

833,334

Wendy Lawrence

(Chief Executive Officer)

 

0

10,000,000

EMI share option

10,000,000

2.51%

1,666,668

833,334

Andy Margolis

(Executive Director)

 

5,125,000

3,000,000

Unapproved share options

8,125,000

2.04%

4,438,770

833,334

Donald Baladasan

(Finance Director)

 

0

6,000,000

Unapproved share options

6,000,000

1.51%

6,778,000

0

Total

5,125,000

24,000,000

-

29,125,000

7.32%

32,615,230

2,500,002

 

 

The Options will vest over a two year period as to one third on the Grant Date and one third on the first and second anniversaries of the Grant Date respectively.

 

All Options granted are also subject to satisfaction of certain performance criteria, being: (i) the closing mid-market price of an ordinary share being 1.5 pence or above over a continuous 60 day trading period prior to exercise; and (ii) the Company reporting audited pre-tax profits in excess of £1.0 million for the year ended 31 December 2015 and £1.75 million for the year ended 31 December 2016. The Options only become exercisable when the performance criteria have been met and expire on the 3rd anniversary of the Grant Date.

 

Following the grant of the Options the total number of options outstanding to subscribe for new ordinary shares in the Company, as at the date of this announcement, is 35,125,000 representing 8.83% of the Company's current issued share capital of which 29,125,000, representing 7.32% of the Company's current issued share capital, are held by existing directors of Totally. In addition, as at the date of this announcement, there are warrants outstanding to subscribe for 142,763,001 new ordinary shares in the Company, equivalent to 35.90 per cent. of the current issued share capital of the Company, which are exercisable at exercise prices ranging from 0.6 pence to 1.2 pence.

 

For further information contact:

Totally Plc / Totally Health

 020 3077 2202

Wendy Lawrence, Chief Executive

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 0203 328 5656

Nick Naylor / Nick Athanas / Alex Brearley

Optiva Securities Limited (Joint Broker)

020 3137 1902

Christian Dennis / Jeremy King

Blytheweigh

020 7138 3203

Tim Blythe / Camilla Horsfall

 

 

Notes to Editors

Totally plc is focused on the provision of professional health coaching which promotes and facilitates self care. Totally's services have been shown to reduce costs for Clinical Commissioning Groups by, for example, reducing unplanned admissions to hospitals and visits to Accident and Emergency Departments.

 

Totally currently operates contracts with NHS England and several CCGs across England delivering their Long Term Condition Management and Shared Decision Making Programs.

 

Totally Health is a provider of a range of services to the healthcare sector that supports individuals to better understand their clinical conditions and support them to avoid exacerbations of such conditions and promote self care.

 

Share Decision Making and the Management of Long Term Conditions are key strategic areas for the NHS in England. The NHS in England estimates that £7 out of every £10 spent on health and social care is spent looking after people diagnosed with a Long Term Condition.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSEEEFSFISEEF
Date   Source Headline
19th Apr 20245:15 pmRNSHolding(s) in Company
19th Apr 20243:00 pmRNSHolding(s) in Company
11th Mar 20247:00 amRNSContract win
7th Mar 20246:00 pmRNSHolding(s) in Company
5th Feb 20247:00 amRNSDirector/PDMR Shareholding
1st Feb 20243:00 pmRNSDirectorate Change
10th Jan 20247:00 amRNSContract Extension
8th Dec 20233:30 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20235:45 pmRNSHolding(s) in Company
1st Dec 20239:33 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSAdviser Update
28th Nov 20237:00 amRNSDirectorate Change
28th Nov 20237:00 amRNSInterim Results
22nd Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
4th Oct 20234:15 pmRNSHolding(s) in Company
11th Sep 202312:00 pmRNSExercise of options and change to TVR
1st Sep 202312:25 pmRNSResult of AGM
1st Sep 20237:00 amRNSAGM Statement
25th Jul 20237:00 amRNSHolding(s) in Company
18th Jul 20234:00 pmRNSExercise of options and change to TVR
13th Jul 20233:30 pmRNSHolding(s) in Company
12th Jul 202312:15 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSDividend Timetable and EPS - Corrections
11th Jul 20237:00 amRNSHolding(s) in Company
10th Jul 20237:00 amRNSPreliminary results
6th Jul 20237:00 amRNSNotice of Preliminary Results
5th Jul 20231:00 pmRNSExercise of options and change to TVR
22nd May 20237:00 amRNSTotally secures multiple contract extensions
16th May 202312:30 pmRNSExercise of options & change to TVR
2nd May 20237:01 amRNSTrading Update for 12 months ending 31 March 2023
2nd May 20237:00 amRNSAppointment of Nomad and Joint Corporate Broker
26th Apr 20237:00 amRNSFurther new contract win for urology services
18th Apr 20237:00 amRNSTotally to help reduce waiting lists in Wales
12th Apr 20237:00 amRNSTotally wins new contract for urology services
4th Apr 20237:00 amRNSTotally first to fully mobilise on NHS SVCC model
31st Mar 20235:00 pmRNSTotal Voting Rights
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
20th Mar 20231:42 pmRNSExercise of options, PDMR shareholding & TVR
16th Mar 20231:34 pmRNSDirector/PDMR Shareholding
10th Mar 20231:49 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSHolding(s) in Company
8th Mar 20232:09 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:05 amRNSSecond Price Monitoring Extn
2nd Mar 20239:00 amRNSPrice Monitoring Extension
2nd Mar 20237:00 amRNSTrading Update
28th Feb 20235:00 pmRNSTotal Voting Rights
3rd Feb 20234:41 pmRNSExercise of options, director/PDMR & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.